Jagsonpal Pharmaceuticals Limited logo

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Market Closed
17 Jan, 22:00
MSE MSE
218. 00
-4.6
-2.07%
- Market Cap
34.78 P/E Ratio
20% Div Yield
7,269 Volume
0 Eps
222.6
Previous Close
Day Range
216.15 227.9
Year Range
108.02 328.02
Earnings results expected in 10 days

Summary

JAGSNPHARM closed Friday lower at ₹218, a decrease of 2.07% from Thursday's close, completing a monthly decrease of -10.89% or ₹26.64. Over the past 12 months, JAGSNPHARM stock lost -10.89%.
JAGSNPHARM is not paying dividends to its shareholders.
The last earnings report, released on Nov 01, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 2.06%, based on the last three reports. The next scheduled earnings report is due on Jan 31, 2025.
Jagsonpal Pharmaceuticals Limited has completed 1 stock splits, with the recent split occurring on Jan 08, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on MSE (INR).
Want to track JAGSNPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

JAGSNPHARM Chart

FAQ

What Is the Jagsonpal Pharmaceuticals Limited(JAGSNPHARM) Stock Price Today?

The JAGSNPHARM stock price today is ₹218.00.

What Stock Exchange Does Jagsonpal Pharmaceuticals Limited Trade On?

Jagsonpal Pharmaceuticals Limited is listed and trades on the XNSE.

What Is the Stock Symbol for Jagsonpal Pharmaceuticals Limited?

The stock symbol for Jagsonpal Pharmaceuticals Limited is "JAGSNPHARM".

Does Jagsonpal Pharmaceuticals Limited Pay Dividends? What's The Current Dividend Yield?

JAGSNPHARM is not paying dividends to its shareholders.

What Is the Jagsonpal Pharmaceuticals Limited Market Cap?

As of today, Jagsonpal Pharmaceuticals Limited does not have a market cap available.

What is Jagsonpal Pharmaceuticals Limited Earnings Per Share?

The Jagsonpal Pharmaceuticals Limited EPS is 0.

What Is the Next Jagsonpal Pharmaceuticals Limited Earnings Date?

Jagsonpal Pharmaceuticals Limited will release its next earnings report on Jan 31, 2025.

Did Jagsonpal Pharmaceuticals Limited had any splits?

Jagsonpal Pharmaceuticals Limited had 1 splits and the recent split was on Jan 08, 2025.

Jagsonpal Pharmaceuticals Limited Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Manish Gupta CEO
MSE Exchange
INE048B01027 ISIN
India Country
1,025 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Jagsonpal Pharmaceuticals Limited is a renowned name in the pharmaceutical industry with a strong focus on manufacturing and trading a diverse range of pharmaceutical products and active pharmaceutical ingredients. Since its inception in 1978, the company has established a strong footprint not only in India but also in various international markets. Jagsonpal Pharmaceuticals specializes in areas such as women's health, pain and analgesics, and general medicine, showcasing a commitment towards addressing a wide spectrum of health issues through its innovative solutions. Headquartered in New Delhi, India, the company stands out for its extensive experience and dedication to quality in the pharmaceutical sector.

Products and Services

Jagsonpal Pharmaceuticals Limited offers a comprehensive array of pharmaceutical formulations and over-the-counter drugs, tailored to meet the specific needs of patients across different therapeutic areas. Below is a detailed list of their products and services:

  • Gynaecology: Their range in gynaecology aims to address various women's health issues, providing effective treatments and medications designed specifically for women. The offerings include a variety of formulations that cater to hormonal balance, fertility treatments, and overall women's health.
  • Orthopaedics: Focused on the treatment and management of orthopaedic conditions, Jagsonpal Pharmaceuticals presents a selection of pain and analgesics products. These are formulated to alleviate pain and inflammation, aiding in the recovery and management of musculoskeletal disorders.
  • Allergy Management: The company also specializes in the development and provision of allergy management medications. These products aim to offer relief from allergic reactions, improving patients' quality of life who suffer from various types of allergies.
  • Pharmaceutical Formulations: Jagsonpal Pharmaceuticals excels in producing high-quality pharmaceutical formulations. These include tablets, softgels, injections, capsules, and syrups, catering to a broad array of health conditions and ensuring versatile therapeutic options for healthcare providers and patients alike.
  • Over The Counter Drugs: Besides prescription medications, the company offers a range of over-the-counter (OTC) drugs. These products are designed to address common health concerns and are available without the need for a prescription, providing convenient and accessible healthcare solutions to the general public.

Contact Information

Address: Plot No. 412-415, Nimai Tower
Phone: 91 12 4440 6710